SCOPUS 정보 검색 플랫폼

Volumn 62, Issue 1, 2015, Pages 239-

HBeAg-positive chronic hepatitis B patients with prior long-time exposure to nucleos(t)ide analogues: "switch-to" or "add-on" PegIFN alfa, that is the question

(2) Chen, Shaolong a Zhang, Wenhong a

a FUDAN UNIVERSITY (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PEGINTERFERON ALPHA2A; VIRUS DNA; ALPHA INTERFERON; GUANINE; MACROGOL DERIVATIVE;

ADD ON THERAPY; ANTIVIRAL THERAPY; CD8+ T LYMPHOCYTE; CELL POPULATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS B; HUMAN; LETTER; LONG TERM EXPOSURE; NATURAL KILLER CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROCONVERSION; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; HEPATITIS B VIRUS; MALE;

FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS;

EID: 84918528543 PISSN: 01688278 EISSN: 16000641 Source Type: Journal
DOI: 10.1016/j.jhep.2014.08.056 Document Type: Letter

Times cited : (3)

References (10)

1
- 84926415822
- Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
- Q. Ning, M. Han, Y. Sun, J. Jiang, D. Tan, and J. Hou Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial) J Hepatol 61 2014 777 784
- (2014) J Hepatol , vol.61 , pp. 777-784
- Ning, Q.¹ Han, M.² Sun, Y.³ Jiang, J.⁴ Tan, D.⁵ Hou, J.⁶

2
- 84861865262
- Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B
- J.M. Kittner, M.F. Sprinzl, A. Grambihler, A. Weinmann, J.M. Schattenberg, and P.R. Galle Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B J Clin Virol 54 2012 93 95
- (2012) J Clin Virol , vol.54 , pp. 93-95
- Kittner, J.M.¹ Sprinzl, M.F.² Grambihler, A.³ Weinmann, A.⁴ Schattenberg, J.M.⁵ Galle, P.R.⁶

3
- 84888839700
- Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs
- D. Ouzan, G. Penaranda, H. Joly, H. Khiri, A. Pironti, and P. Halfon Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs J Clin Virol 58 2013 713 717
- (2013) J Clin Virol , vol.58 , pp. 713-717
- Ouzan, D.¹ Penaranda, G.² Joly, H.³ Khiri, H.⁴ Pironti, A.⁵ Halfon, P.⁶

4
- 84918580025
- Sequential combination therapy with NUCs and Peg-IFN in HBeAG positive CHB patients with prior long-term exposure to NUCs
- O117
- Li G, Yu Y, Chen S, Fan, P, Zhang W. Sequential combination therapy with NUCs and Peg-IFN In HBeAG positive CHB patients with prior long-term exposure to NUCs. EASL 2014, O117.
- (2014) EASL
- Li, G.¹ Yu, Y.² Chen, S.³ Fan, P.⁴ Zhang, W.⁵

5
- 84872380975
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-Alpha therapy of chronic hepatitis B
- L. Micco, D. Peppa, E. Loggi, A. Schurich, L. Jefferson, and C. Cursaro Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-Alpha therapy of chronic hepatitis B J Hepatol 58 2013 225 233
- (2013) J Hepatol , vol.58 , pp. 225-233
- Micco, L.¹ Peppa, D.² Loggi, E.³ Schurich, A.⁴ Jefferson, L.⁵ Cursaro, C.⁶

6
- 84874543706
- Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
- D. Peppa, U.S. Gill, G. Reynolds, N.J. Easom, L.J. Pallett, and A. Schurich Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion J Exp Med 210 2013 99 114
- (2013) J Exp Med , vol.210 , pp. 99-114
- Peppa, D.¹ Gill, U.S.² Reynolds, G.³ Easom, N.J.⁴ Pallett, L.J.⁵ Schurich, A.⁶

7
- 84866705034
- Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues
- C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, and S. Schivazappa Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 143 2012 e969
- (2012) Gastroenterology , vol.143 , pp. 969
- Boni, C.¹ Laccabue, D.² Lampertico, P.³ Giuberti, T.⁴ Vigano, M.⁵ Schivazappa, S.⁶

8
- 84890551259
- Reduction of HBV replication prolongs the early immunological response to IFNalpha therapy
- A.T. Tan, L.T. Hoang, D. Chin, E. Rasmussen, U. Lopatin, and S. Hart Reduction of HBV replication prolongs the early immunological response to IFNalpha therapy J Hepatol 60 2014 54 61
- (2014) J Hepatol , vol.60 , pp. 54-61
- Tan, A.T.¹ Hoang, L.T.² Chin, D.³ Rasmussen, E.⁴ Lopatin, U.⁵ Hart, S.⁶

9
- 84896029673
- Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA
- J. Lucifora, Y. Xia, F. Reisinger, K. Zhang, D. Stadler, and X. Cheng Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 343 2014 1221 1228
- (2014) Science , vol.343 , pp. 1221-1228
- Lucifora, J.¹ Xia, Y.² Reisinger, F.³ Zhang, K.⁴ Stadler, D.⁵ Cheng, X.⁶

10
- 84872369702
- Dissecting the divergent effects of interferon-Alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?
- R. Thimme, and M. Dandri Dissecting the divergent effects of interferon-Alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? J Hepatol 58 2013 205 209
- (2013) J Hepatol , vol.58 , pp. 205-209
- Thimme, R.¹ Dandri, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.